» Articles » PMID: 8389767

Receptor-mediated Endocytosis of Tissue-type Plasminogen Activator by Low Density Lipoprotein Receptor-related Protein on Human Hepatoma HepG2 Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1993 Jun 15
PMID 8389767
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic parenchymal cells play an essential role in the clearance of circulating tissue-type plasminogen activator (t-PA) in vivo as a major pathway in the regulation of plasma fibrinolytic activity. Previous studies have identified plasminogen activator inhibitor type 1 (PAI-1)-dependent t-PA-binding sites in the human hepatoma cell line HepG2. In this study, we demonstrate that receptor-mediated binding and endocytosis of the t-PA-PAI-1 complex are largely mediated by a recently identified low density lipoprotein receptor-related protein (LRP). A 39-kDa LRP receptor-associated protein that modulates ligand binding to LRP was found to bind specifically to HepG2 cells and to inhibit approximately 70-80% of specific 125I-t-PA.PAI-1 binding. This inhibition by the 39-kDa protein was not due to inhibition of complex formation between 125I-t-PA and PAI-1; instead, the 39-kDa protein inhibited 125I-t-PA.PAI-1 binding to LRP. Polyclonal anti-LRP antibody raised against purified human LRP also inhibited 70-80% of specific 125I-t-PA.PAI-1 binding. A similar extent of inhibition by the 39-kDa protein was also observed for 125I-t-PA.PAI-1 endocytosis and degradation. Chemical cross-linking experiments demonstrated the direct interaction between 125I-t-PA.PAI-1 and LRP on HepG2 cells as anti-LRP antibody, in addition to anti-t-PA and anti-PAI-1 antibodies, was able to immunoprecipitate the 125I-t-PA.PAI-1 complex following binding of 125I-t-PA.PAI-1 to HepG2 cells and cross-linking. This interaction of the t-PA.PAI-1 complex with LRP on HepG2 cells was also observed when the unlabeled t-PA.PAI-1 complex was cross-linked to [35S]methionine-labeled HepG2 cells. In addition, the direct binding of the 39-kDa protein to LRP on HepG2 cells was demonstrated by similar cross-linking experiments. Thus, these data clearly show that LRP is the major cell-surface receptor responsible for t-PA.PAI-1 complex binding and endocytosis on human hepatoma HepG2 cells and extend the multifunctional nature of LRP as an endocytosis receptor for several structurally and functionally distinct ligands.

Citing Articles

Neuroserpin: structure, function, physiology and pathology.

DAcunto E, Fra A, Visentin C, Manno M, Ricagno S, Galliciotti G Cell Mol Life Sci. 2021; 78(19-20):6409-6430.

PMID: 34405255 PMC: 8558161. DOI: 10.1007/s00018-021-03907-6.


Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.

Das L, Azmoon P, Banki M, Mantuano E, Gonias S PLoS One. 2019; 14(11):e0224738.

PMID: 31697716 PMC: 6837328. DOI: 10.1371/journal.pone.0224738.


Low Density Lipoprotein Receptor Related Proteins as Regulators of Neural Stem and Progenitor Cell Function.

Auderset L, Landowski L, Foa L, Young K Stem Cells Int. 2016; 2016:2108495.

PMID: 26949399 PMC: 4754494. DOI: 10.1155/2016/2108495.


Retina Is Protected by Neuroserpin from Ischemic/Reperfusion-Induced Injury Independent of Tissue-Type Plasminogen Activator.

Gu R, Fu L, Jiang C, Xu Y, Wang X, Yu J PLoS One. 2015; 10(7):e0130440.

PMID: 26176694 PMC: 4503687. DOI: 10.1371/journal.pone.0130440.


LRP1 shedding in human brain: roles of ADAM10 and ADAM17.

Liu Q, Zhang J, Tran H, Verbeek M, Reiss K, Estus S Mol Neurodegener. 2009; 4:17.

PMID: 19371428 PMC: 2672942. DOI: 10.1186/1750-1326-4-17.